SACLAC
SACLAC, a Ceramide analog, is a potent and covalent acid ceramidase (ASAH1; AC) inhibitor with a Ki of 97.1 nM. SACLAC effectively blocks AC activity and induces a decrease in sphingosine 1-phosphate (S1P) and total ceramide levels. SACLAC reduces the levels of splicing factor SF3B1 and alternative Mcl-1 mRNA splicing, increases pro-apoptotic Mcl-1S levels to induce apoptosis in acute myeloid leukemia (AML) cells. SACLAC reduces the leukemic burden in human AML xenograft mouse models[1][2].
Product Specifications
CAS Number
2248703-42-4
UNSPSC
12352211
Target
Apoptosis; Bcl-2 Family; Ceramidase; LPL Receptor
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/saclac.html
Purity
99.70
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(CCl)=O
Molecular Formula
C20H40ClNO3
Molecular Weight
377.99
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD19 (CVID3/429), CF740 conjugate, 0.1mg/mL
CD22 / BL-CAM (B-Cell Marker) (BLCAM/1796), CF594 conjugate, 0.1mg/mL
CD51 (ITGAV) (NM_001144999) Human Over-expression Lysate
